Press Releases Amphastar Pharmaceuticals, Inc.

Equities

AMPH

US03209R1032

Market Closed - Nasdaq Other stock markets 21:00:00 10/05/2024 BST			5-day change	1st Jan Change
42.21 ^USD	-0.52%		-0.59%	-31.75%

05-08	Transcript : Amphastar Pharmaceuticals, Inc., Q1 2024 Earnings Call, May 08, 2024
05-08	Amphastar Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended March 31, 2024	05-09	AQ
Amphastar: Q1 Earnings Snapshot	05-08	AQ
Amphastar Pharmaceuticals to Present at the 23rd Annual Needham Virtual Healthcare Conference	04-02	AQ
Amphastar Pharmaceuticals Reports Financial Results for the Three Months and Full-Year Ended December 31, 2023	02-29	AQ
Amphastar: Q4 Earnings Snapshot	02-28	AQ
Amphastar Pharmaceuticals to Release Fourth Quarter Earnings and Hold Conference Call on February 28, 2024	02-21	AQ
Amphastar Pharmaceuticals to Present at the 42nd Annual J.P. Morgan Healthcare Conference	01-03	AQ
Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended September 30, 2023	11-09	AQ
Amphastar: Q3 Earnings Snapshot	11-09	AQ
Amphastar Pharmaceuticals to Release Third Quarter Earnings and Hold Conference Call on November 8, 2023	11-02	AQ
Amphastar Pharmaceuticals Announces Pricing of Offering of $300.0 Million of Convertible Senior Notes	14/09/23	AQ
Amphastar Pharmaceuticals Announces Proposed Private Offering of $300.0 Million of Convertible Senior Notes	12/09/23	AQ
Amphastar Pharmaceuticals to Present at the Wells Fargo Healthcare Conference	01/09/23	AQ
Amphastar: Q2 Earnings Snapshot	09/08/23	AQ
Amphastar: Q1 Earnings Snapshot	09/05/23	AQ
AMPHASTAR PHARMACEUTICALS, INC. : Results of Operations and Financial Condition, Financial Statements and Exhibits (form 8-K)	09/05/23	AQ
AMPHASTAR PHARMACEUTICALS, INC. : Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Other Events, Financial Statements and Exhibits (form 8-K)	24/04/23	AQ
Lilly to Divest BAQSIMI to Amphastar	24/04/23	PR
AMPHASTAR PHARMACEUTICALS, INC. : Entry into a Material Definitive Agreement (form 8-K)	10/03/23	AQ
AMPHASTAR PHARMACEUTICALS, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-K)	01/03/23	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Amphastar Pharmaceuticals, Inc.

Equities

AMPH

US03209R1032

Press Releases

Filters